Dicerna (DRNA) To Report Third Quarter 2016 Financial Results And Host Conference Call On November 7, 2016
11/1/2016 11:39:14 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational RNA interference (RNAi) therapeutics, today announced that the Company will release its third quarter 2016 financial results after market close on Monday, November 7, 2016.
Management will conduct a conference call at 4:30 p.m. ET that day to discuss the Company's financial results and provide a general business update. The conference call will be webcast live via the internet and will be available on the “Investors & Media” section of the Dicerna website, www.dicerna.com. The webcast will also be archived on the Company's website.
comments powered by